Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Drreddys Laboratories

Drreddys Laboratories reported INR230.99B in Equity Capital and Reserves for its fiscal quarter ending in March of 2023.

Equity Capital And Reserves Change
ANI Pharmaceuticals ANIP:US USD 339.48M 942K
Bayer BAYN:GR EUR 40.86B 2.09B
Catalent CTLT:US USD 4.91B 212M
Corcept Therapeutics CORT:US USD 529.58M 27.74M
Drreddys Laboratories RDY:US INR 230.99B 10.72B
Endo International ENDP:US USD -4153605000 8.57M
GlaxoSmithKline GSK:LN GBP 11.82B 1.22B
Hikma Pharmaceutical HIK:LN USD 2.14B 41M
Horizon Pharma HZNP:US USD 5.1B 23.39M
Lonza Group LONN:SW CHF 10.6B 586M
Novartis NOVN:VX USD 52.06B 7.28B
Pacira PCRX:US USD 768.04M 6.97M
Phibro Animal Health PAHC:US USD 272.33M 3.96M
Prestige Brands PBH:US USD 1.45B 239.78M
Richter Gedeon RICHT:HB HUF 1.09T 38.55B
Supernus Pharmaceuticals SUPN:US USD 912.15M 25.95M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 7.86B 36M